| Market Cap | ₹1,693Cr |
| ROE | 12.60% |
| P/E Ratio(TTM) | 25.37 |
| EPS(TTM) | 31.67 |
| P/B Ratio | 3.17 |
| Dividend Yield | 0.72% |
| Industry P/E | 32.04 |
| Book Value | 253.39 |
| Debt to Equity | 0.06 |
| Face Value | 5 |
| Managing Director | Hitesh Windlass |
| Founded | 2001 |
| NSE Symbol | WINDLAS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 64.43 | ||
| Ajanta Pharma | NA (0.00%) | 35.94 | ||
| Gland Pharma | NA (0.00%) | 34.61 | ||
| Eris Lifesciences | NA (0.00%) | 43.65 |